West Pharmaceutical Services Aktie
WKN: 864330 / ISIN: US9553061055
|
24.04.2025 12:29:54
|
West Pharmaceutical Services Inc. Q1 Profit Decreases, But Beats Estimates
(RTTNews) - West Pharmaceutical Services Inc. (WST) revealed a profit for first quarter that decreased from last year but beat the Street estimates.
The company's bottom line totaled $89.8 million, or $1.23 per share. This compares with $115.3 million, or $1.55 per share, last year.
Excluding items, West Pharmaceutical Services Inc. reported adjusted earnings of $106.2 million or $1.45 per share for the period.
Analysts on average had expected the company to earn $1.23 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 0.4% to $698.0 million from $695.4 million last year.
West Pharmaceutical Services Inc. earnings at a glance (GAAP) :
-Earnings: $89.8 Mln. vs. $115.3 Mln. last year. -EPS: $1.23 vs. $1.55 last year. -Revenue: $698.0 Mln vs. $695.4 Mln last year.
-Guidance: Full year EPS guidance: $6.15 to $6.35
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!